| RS774131564 |
PEX7
|
Health Risk |
Pathogenic/Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Peroxisome biogenesis disorder 9B |
| RS774131656 |
FA2H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 35, Spastic paraplegia |
| RS774131659 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS774131854 |
RAB27A
|
Health Risk |
Pathogenic |
Griscelli syndrome type 2, Griscelli syndrome type 2 |
| RS774132406 |
PHGDH
|
Health Risk |
Conflicting classifications of pathogenicity |
PHGDH deficiency, Inborn genetic diseases |
| RS774132595 |
GPHN
|
Health Risk |
Conflicting classifications of pathogenicity |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Inborn genetic diseases |
| RS774132615 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Intellectual disability |
| RS774132884 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS774133574 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS774133746 |
LAMA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Epidermolysis bullosa |
| RS774135330 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS774136369 |
DNAAF3
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS774136727 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS774136809 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS774137001 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 6, Dilated cardiomyopathy 1HH |
| RS774137928 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS774139166 |
LTBP2
|
Health Risk |
Likely pathogenic |
Glaucoma 3, primary congenital |
| RS774139365 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Inborn genetic diseases |
| RS774139970 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS774142518 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS774143246 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS774143329 |
ASPM
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly 5, primary |
| RS77414333 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, OTOF-related disorder |
| RS774144071 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome 3, Joubert syndrome 3 |
| RS774144118 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS774144200 |
GAMT
|
Health Risk |
Pathogenic |
Cerebral creatine deficiency syndrome, Deficiency of guanidinoacetate methyltransferase |
| RS774144789 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder |
| RS774145606 |
TRPV1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS774146015 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS774146374 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS774147100 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS774148061 |
LRRK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS774148221 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome 1 |
| RS774148469 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS774148781 |
ARFGEF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental delay, impaired speech |
| RS774148938 |
PCNT
|
Health Risk |
Likely pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, PCNT-related disorder |
| RS774149338 |
CYP2U1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS774150500 |
APOA5
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertriglyceridemia 1, Familial type 5 hyperlipoproteinemia |
| RS774152293 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS774152349 |
ABCA12
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital ichthyosis of skin, Congenital ichthyosis of skin |
| RS774152851 |
CHD8
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Autism spectrum disorder |
| RS774153227 |
TRMU
|
Health Risk |
Pathogenic/Likely pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Aminoglycoside-induced deafness |
| RS774153480 |
ARSA
|
Health Risk |
Pathogenic/Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS774156512 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS774157225 |
TSEN54
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia type 2A, Pontoneocerebellar hypoplasia |
| RS774158046 |
MATR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 21, MATR3-related disorder |
| RS774158999 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS774159224 |
ABCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS774159573 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS774159791 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic acidemia, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS774159828 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS774160105 |
SUMF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS774160163 |
GBE1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type IV |
| RS774160524 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS774160640 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS774161532 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS774162169 |
NPHP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, NPHP1-related disorder |
| RS774162322 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS774162709 |
NDUFS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS774163062 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS774163084 |
EIF2AK4
|
Health Risk |
Pathogenic |
Familial pulmonary capillary hemangiomatosis, Familial pulmonary capillary hemangiomatosis |
| RS774163551 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS774164327 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS774166976 |
REN
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial juvenile hyperuricemic nephropathy type 2, Renal tubular dysgenesis |
| RS774167945 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS774168080 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS774168389 |
GPSM2
|
Health Risk |
Likely pathogenic |
Chudley-McCullough syndrome, Chudley-McCullough syndrome |
| RS774168858 |
IL12RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Inborn genetic diseases |
| RS774169230 |
GARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Parkinsonian disorder |
| RS774170058 |
FANCC
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group C |
| RS774170824 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Retinal dystrophy |
| RS774172072 |
RUNX2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS774172292 |
OTOGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 84B, Autosomal recessive nonsyndromic hearing loss 84B |
| RS774174074 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS774174881 |
LAMB3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa |
| RS774174988 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS774175654 |
CHEK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS774175693 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS774175886 |
ERCC6
|
Health Risk |
Pathogenic/Likely pathogenic |
Cockayne syndrome type 2, Cockayne syndrome type 2 |
| RS774176392 |
TTC19
|
Health Risk |
Conflicting classifications of pathogenicity |
TTC19-related disorder, Inborn genetic diseases |
| RS774177833 |
AHDC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS774178055 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Kabuki syndrome |
| RS774178253 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant tumor of breast, Familial cancer of breast |
| RS774179857 |
MNX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Currarino triad, Inborn genetic diseases |
| RS774180632 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS774182356 |
SLC26A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS774183791 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, 7 conditions |
| RS774184465 |
PNPLA8
|
Health Risk |
Pathogenic |
Mitochondrial myopathy-lactic acidosis-deafness syndrome, Mitochondrial myopathy-lactic acidosis-deafness syndrome |
| RS774184754 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS774185390 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS774185980 |
CLPB
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria, type VIIB |
| RS774186159 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS774186716 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS774187452 |
DHCR7
|
Health Risk |
Pathogenic/Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS774188472 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS774188638 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS774190967 |
ALDH7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS774191944 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS774191975 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS774192195 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |